diphenylamine has been researched along with Cell Transformation, Neoplastic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afify, SM; Alam, MJ; Chen, L; Du, J; Hassan, G; Khayrani, AC; Kumon, K; Mahmud, H; Mansour, HM; Nair, N; Okada, N; Oo, AKK; Sasada, S; Seno, A; Seno, M; Uesaki, R; Xu, Y; Yan, T; Zahra, MH | 1 |
| Brekken, RA; Buettner, R; Chatterjee, S; Christofori, G; Frasca, D; Heukamp, LC; Koker, M; König, K; Meder, L; Neumaier, B; Peifer, M; Rauh, D; Schöttle, J; Siobal, M; Thomas, RK; Ullrich, RT; Wieczorek, C; Wolf, J | 1 |
| Carlson, SG; Chen, Z; Cheng, H; Coupar, JF; Eytan, DF; Mohan, S; Pierce, ML; Shah, S; Van Waes, C; Vander Broek, R; Zhang, J | 1 |
| Atrott, K; Cosin-Roger, J; Curioni-Fontecedro, A; Kiessling, MK; Lang, S; Rogler, G; Samaras, P; Scharl, M | 1 |
| Kaihoh, S; Ohizumi, I; Tanemura, M | 1 |
5 other study(ies) available for diphenylamine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
Topics: Animals; Benzamides; Carcinoma, Lewis Lung; Cell Transformation, Neoplastic; Cells, Cultured; Dasatinib; Diphenylamine; Enzyme Inhibitors; Female; Induced Pluripotent Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Tumor Microenvironment | 2020 |
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Diphenylamine; Feedback, Physiological; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Neovascularization, Pathologic; Piperidines; Quinazolines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cytokines; Diphenylamine; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Genes, Reporter; Head and Neck Neoplasms; Humans; Inflammation Mediators; Mitogen-Activated Protein Kinase Kinases; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcriptional Activation; Triazines; Xenograft Model Antitumor Assays | 2015 |
Mutant HRAS as novel target for MEK and mTOR inhibitors.
Topics: Animals; Apoptosis; Benzamides; Benzimidazoles; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Diphenylamine; Humans; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Diphenylamine; Female; Fibrosarcoma; Genes, ras; Humans; L Cells; Leukemia P388; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Teratocarcinoma; Tumor Cells, Cultured | 1995 |